Signaling Pathways
-
A4115 JNJ-77066211 CitationTarget: Cyclin-Dependent Kinases|Aurora KinasesSummary: Potent CDK/Aurora kinase inhibitor
-
A1115 Peptide YY(3-36), PYY, humanTarget: NPY ReceptorsSummary: Y2R agonist
-
A4118 Hesperadin1 CitationTarget: Aurora KinasesSummary: Aurora B kinase inhibitor
-
A4123 KW 2449Target: Aurora Kinases|FLT3|Bcr-AblSummary: Multikinase inhibitor
-
A4126 Aurora A Inhibitor ITarget: Aurora KinasesSummary: Aurora A inhibitor
-
A4127 GSK1070916Target: Aurora KinasesSummary: Aurora B/C inhibitor
-
A4128 PF-03814735Target: Aurora KinasesSummary: Aurora A/B inhibitor
-
A4210 Bay 11-7821 (BAY 11-7082)1 CitationSummary: IKK/NF-κB/TNFα inhibitor
-
A4211 Lenalidomide (CC-5013)Target: angiogenesisSummary: Antineoplastic agent,inhibits angiogenesis
-
A4212 Pomalidomide (CC-4047)Summary: Immunomodulator,antumor/anti-angiogenic